Stay updated on Long-term Baricitinib in Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the Long-term Baricitinib in Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Long-term Baricitinib in Atopic Dermatitis Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The record presents details of the completed Phase 3 BREEZE-AD3 study of long-term baricitinib therapy for atopic dermatitis, including eligibility criteria, study arms and outcome measures. It also provides results-related measures, participating locations, publications, and study documents.
    Difference
    100%
    Check dated 2026-11-09T12:54:48.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The page continues to display a 403 Forbidden error. The footer revision identifier changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-02T12:25:38.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    A banner announces an NIH website transition and says that some content may use “Super Intelligence” instead of “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-26T12:20:46.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    The footer now identifies the site as revision v3.7.2 instead of v3.7.1.
    Difference
    0.3%
    Check dated 2026-10-19T12:58:44.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The site footer revision identifier changes from v3.7.0 to v3.7.1.
    Difference
    0.3%
    Check dated 2026-10-12T14:31:52.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden message, indicating restricted access, and the previously listed study content and documents are removed, altering how the study information is presented.
    Difference
    20%
    Check dated 2026-09-21T20:48:57.000Z thumbnail image

Stay in the know with updates to Long-term Baricitinib in Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Long-term Baricitinib in Atopic Dermatitis Clinical Trial page.